key: cord-0896572-r08jm3c5 authors: Wang, Heyan; He, Hangyong title: Find the real responders and improve the outcome of awake prone positioning date: 2021-07-08 journal: Crit Care DOI: 10.1186/s13054-021-03663-w sha: ca1492eea0c286258c5065bae06f5d05567fc129 doc_id: 896572 cord_uid: r08jm3c5 nan We read with great interest of the report by Rosen and colleagues [1] about the effect of awake prone positioning (APP) on intubation rate among patients with moderate to severe hypoxemic respiratory failure (HRF) due to COVID-19. They identified a implemented protocol for APP increased duration of prone positioning, but did not reduce the rate of intubation compared to standard care. From our point of view, some details about whether APP could decrease intubation in patients with HRF due to COVID-19 need to be further clarified. First, in Rosen's study [1] , the patient in standard care group also received a median prone duration of 3.4 h compared with 9.0 h per day in the prone group, which means that the real intervention factor they investigated was whether a prolonged APP could further decrease intubation rate. Therefore, it may be more appropriate to draw a conclusion that prolonged APP did not reduce the rate of intubation in patients with HRF due to COVID-19. Second, Rosen and colleagues [1] reported a 33% intubation rate in both groups, which is much lower than that reported in two other studies [2, 3] with similar baseline characteristics, degree of respiratory failure but shorter APP duration (41% and 49% in the control group and 40% and 58% in the prone group) compared with their investigation. Based on this data, could we speculate that prolonged APP does decrease the intubation rate? Third, in Rosen's study [1] , most patients were put on APP when they were supported with noninvasive ventilation, which is a higher level support than high flow nasal canula (HFNC) [4] . This may indicate that they use the APP more like a "rescue" therapy rather than an "adjunctive" therapy in a late stage of ARF, which may get less response to APP and therefore less difference in intubation rate. In summary, combining this lack of accuracy of comparison of APP and non-APP patients, and the possibly late initiation of APP in the moderate to severe ARF COVID-19 patients, a priori chance of finding a difference in intubation was low and may explain the negative findings for the APP. And further analysis with data from comparison of non-APP populations and prolonged APP group, especially in patients support with HFNC and prolonged APP, is needed for a more settled conclusion. Ready to submit your research Ready to submit your research ? Choose BMC and benefit from: ? Choose BMC and benefit from: Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial Awake prone positioning does not reduce the risk of intubation in COVID-19 treated with high-flow nasal oxygen therapy: a multicenter, adjusted cohort study Awake prone positioning in COVID-19 hypoxemic respiratory failure: exploratory findings in a single-center retrospective cohort study Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations None. Authors' contributions HW and HH are responsible for study design and writing. Both authors read and approved the final manuscript. None. Not applicable. Ethics approval and consent to participate Not applicable. Not applicable. The authors declare that they have no competing interests.